Nanotechnology makes use of biotechnology

Nanotechnology applications are pushing the boundaries of a number of sectors including electronics. New research in the field of microelectronics facilitates the manufacture of nanodevices at the molecular level based on the use of genetic material.

The EC-funded MINT project focused on the level of interconnections that can be achieved in the new generation of nanodevices. The aim was to achieve at least the same level of interconnections as those in microelectronic systems. Project partners investigated the potential role of ribonucleic acid (RNA) as part of the manufacturing process of original templates.

RNA folds into specific tertiary structures giving researchers the opportunity to exploit this property in order to form new templates for the design of novel nanodevices. Within the framework of MINT, the University of Liverpool designed and characterised a series of self-assembling RNA molecules for the purposes of nanofabrication.

These RNA structures combine either in twos or in fours to form one-dimensional fibres in the presence of magnesium ions. These structures have been designed to facilitate specific and non-specific attachment of RNA molecules to gold nanoparticles, electrodes or surfaces. The resulting RNA-gold fibres have been used successfully as templates for electrochemical deposition of metal on gold surfaces. The aim is to form nanointerconnections between the varied components.

The University is seeking further support to continue this line of research. The applications of this project could have a profound effect on the field of nanotechnology and in particular in the area of nanoelectronics.

Contact Details
BATES, Andy (Dr)
University of Liverpool
Lecturer in Molecular Biology
School of Biological Sciences
L69 7ZB
Liverpool
UNITED KINGDOM
Tel: +44-1517-954563
Fax: +44-1517-954410
URL: http://www.liv.ac.uk/bio/

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...